Dargistotug

达吉苏塔单抗

Report date: 2024/01/02 20:03:52

Base Information

Drug NameDargistotug
Drug Alias NameM-6223M6223
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody human
Mechanisms of ActionAnti-T cell immunoglobulin and ITIM domains
TargetsT cell immunoglobulin and ITIM domains
Therapy Area/IndicationsSolid tumoursCarcinoma, Transitional Cell
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryBelgiumCanadaUnited States +[12] 
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesEmd Serono Research & Development Institute Inc
China Registration ClassN/A

Develop Information

Active CompaniesEmd Serono Research & Development Institute IncMerck KGaA, Darmstadt, Germany
Inactive CompaniesN/A
Active IndicationsSolid tumoursCarcinoma, Transitional Cell
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A